Bioharvest Competitors

Delisted . USA . 
Stock . Bioharvest Sciences
CNVCFDelisted Stock  USD 5.13  0.07  1.35%   
Bioharvest Sciences competes with BAB, Premier Foods, A2 Milk, Artisan Consumer, and Avi; as well as few others. The company classifies itself under Healthcare sector and is part of Drug Manufacturers—Specialty & Generic industry. Analyzing Bioharvest Sciences competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Bioharvest Sciences to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Bioharvest Sciences competition on your existing holdings.
  
Specify up to 10 symbols:
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Bioharvest Sciences' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
2.965.137.30
Details
Intrinsic
Valuation
LowRealHigh
2.394.566.73
Details

Bioharvest Sciences Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Bioharvest Sciences and its competitors represents the degree of relationship between the price movements of corresponding otcs. A correlation of about +1.0 implies that the price of Bioharvest and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Bioharvest Sciences does not affect the price movement of the other competitor.
Click cells to compare fundamentals   Check Volatility   Backtest Portfolio
High positive correlations   
SSMTF
+ 1.0
NSPDF
TQLB
+ 0.84
BLEG
BABYF
+ 0.49
BABB
TQLB
+ 0.47
BABB
TQLB
+ 0.44
PRRFY
BABB
+ 0.43
BLEG
  
High negative correlations   
PRRFY
- 0.2
CULTF
PRRFY
- 0.2
BABB
TQLB
- 0.17
CULTF
PRRFY
- 0.15
BABYF
CULTF
- 0.12
BLEG
SSMTF
- 0.0
INBP

Risk-Adjusted Indicators

There is a big difference between Bioharvest OTC Stock performing well and Bioharvest Sciences OTC Stock doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Bioharvest Sciences' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
BLEG  8.85  1.49  0.10  20.00  8.02 
(23.96)
 33.33 
(16.67)
 80.00 
BABB  2.71  0.18  0.04  0.07  3.45 
(3.26)
 5.68 
(7.14)
 17.98 
CULTF  4.73 (0.06) 0.00 (0.25) 0.00 
 0.00 
 11.83 
(10.71)
 32.20 
BABYF  11.32  1.68  0.05  0.10  12.74 
(18.50)
 30.77 
(23.53)
 121.43 
PFODF  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
 0.00 
 0.00 
PRRFY  0.64 (0.02) 0.00  0.06  0.00 
 0.00 
 3.23 
(2.77)
 15.54 
TQLB  8.86  2.44  0.07  0.43  9.81 
(43.61)
 55.56 
(15.38)
 114.67 
NSPDF  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
 0.00 
 0.00 
INBP  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
 0.00 
 0.00 
SSMTF  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
 0.00 
 0.00 
All Fundamental Data

Bioharvest Sciences Competitive Analysis

The better you understand Bioharvest Sciences competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Bioharvest Sciences' competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Bioharvest Sciences' competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
CNVCF BLEG BABB CULTF BABYF PRRFY TQLB NSPDF SSMTF ACOPY
 1.35 
 5.13 
Bioharvest
 16.67 
 0.0007 
Branded
 1.23 
 0.82 
BAB
 15.21 
 0.03 
Cult
 23.08 
 0.01 
Else
 3.23 
 12.15 
Premier
 19.23 
 0 
Torque
 0.00 
 0.04 
Naturally
 0.00 
 0 
SSMTF
 0.00 
 4.85 
ACOPY
Market Volatility
(90 Days Market Risk)
Slightly risky
Out of control
Extremely Dangerous
Out of control
Out of control
Not too volatile
Out of control
Not too volatile
Very steady
Risky
Market Performance
(90 Days Performance)
Very Weak
Modest
Very Weak
Very Weak
Modest
Weak
Insignificant
Very Weak
Very Weak
OK
Odds of Financial Distress
(Probability Of Bankruptcy)
Dangerous
High
Low
Quite High
Low
Below Average
Quite High
High
Unknown
Low
Current Valuation
(Equity Enterprise Value)
Over Valued
Over Valued
Over Valued
Over Valued
Under Valued
Fairly Valued
Under Valued
Over Valued
Over Valued
Over Valued
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Not Rated
Strong Sell
Cautious Hold
Strong Sell
Cautious Hold
Cautious Hold
Cautious Hold
Strong Sell
Strong Sell
Sell
Current Ratio
0.69
3.27
1.95
5.0
9.7
0.89
0.35
0.24
2.66
Net Asset
10.21 M
120.4 K
4.46 M
6.45 M
32.92 M
2.53 B
N/A
4.27 M
1.72 B
Profit Margin
-2.69
N/A
0.13
N/A
-1.32
0.1
N/A
N/A
0.0849
EBITDA
(8.63 M)
(313.8 K)
546.84 K
(2.55 M)
(17.34 M)
166.8 M
N/A
(2.27 M)
210.2 M
Operating Margin
-2.45
-3.17
0.16
N/A
-2.62
0.14
N/A
-7.28
0.12
Current Valuation
106.97 M
4.82 M
4.01 M
4.49 M
32.34 M
1.54 B
37.39 K
2.24 M
2.94 B
Price To Book
91.96
471.32
1.77
1.25
3.0
0.62
N/A
1.02
4.49
Retained Earnings
N/A
N/A
(11.01 M)
N/A
N/A
N/A
N/A
(9.75 M)
N/A
Current Asset
N/A
N/A
1.61 M
N/A
N/A
173.3 M
N/A
1.94 M
N/A
Five Year Return
N/A
N/A
5.13
N/A
N/A
N/A
N/A
N/A
N/A
Beta
1.02
0.67
0.15
0.6
2.1
1.19
2.66
2.1
-0.0967
Number Of Employees
6
3
12
2
28
4 K
2
16
427
Shares Outstanding
460.72 M
438.98 M
7.26 M
174.41 M
112.6 M
172.69 M
221.51 K
22.04 M
731.71 M
Cash Flow From Operations
(6.79 M)
(269.92 K)
718.3 K
(1.64 M)
(15.76 M)
90.1 M
(61.12 K)
(1.21 M)
203.8 M
Annual Yield
N/A
N/A
0.0498
N/A
N/A
0.0104
N/A
N/A
N/A
Total Debt
3.97 M
420.55 K
181.07 K
N/A
687 K
323.2 M
1.23 M
1.37 M
66.21 M
Return On Equity
-63.64
N/A
0.14
-1.16
-0.65
0.0676
N/A
-3.38
0.1
Z Score
11.4
-1.8
17.6
N/A
49.2
1.8
N/A
-2.8
31.2
Return On Asset
-0.53
-0.84
0.0726
-0.66
-0.52
0.0337
N/A
-0.65
0.0718
Book Value Per Share
-0.008
-0.019
0.42
0.03
0.18
8.86
N/A
-0.1
1.59
Number Of Shares Shorted
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Current Liabilities
N/A
N/A
1.05 M
N/A
N/A
214.1 M
N/A
1.71 M
N/A
Total Asset
10.21 M
120.4 K
4.46 M
6.45 M
32.92 M
2.53 B
N/A
4.27 M
1.72 B
Debt To Equity
1.62
N/A
0.059
N/A
0.028
0.23
3.26
3.05
0.1
Last Dividend Paid
N/A
N/A
0.04
N/A
N/A
0.012
N/A
N/A
N/A
Short Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Target Price
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Shares Owned By Institutions
N/A
N/A
N/A
N/A
0.46
N/A
N/A
N/A
N/A
Market Capitalization
75.88 M
3.58 M
6.21 M
6.66 M
56.49 M
1.21 B
443.02 K
947.79 K
3.49 B
Price To Earning
N/A
N/A
15.2
N/A
N/A
11.38
N/A
-2.4
55.41
Price To Earnings To Growth
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
1.68
Price To Sales
28.13
50.09
1.72
N/A
6.18
1.24
N/A
3.67
2.42
Net Income
(9.83 M)
(313.8 K)
651.12 K
(2.55 M)
(1.62 M)
77.5 M
(58.85 K)
(3.14 M)
122.62 M
Earnings Per Share
-0.012
-0.003
0.05
-0.037
-0.15
0.63
-0.052
-0.014
0.1
Shares Owned By Insiders
35.15
18.52
33.67
0.5
33.6
N/A
N/A
9.0
N/A
Revenue
2.1 M
64.25 K
3.07 M
N/A
4.69 M
900.5 M
3.05 M
763.8 K
1.44 B
Working Capital
N/A
N/A
561 K
N/A
N/A
(40.8 M)
N/A
232 K
N/A
Cash And Equivalents
1.21 M
783
1.54 M
458.77 K
20.86 M
54.3 M
770.48 K
120.23 K
887.31 M
Cash Per Share
N/A
N/A
0.21
N/A
0.19
0.32
0.69
N/A
1.19
Gross Profit
670 K
22.65 K
2.07 M
N/A
743 K
327.1 M
(598 K)
(132.1 K)
663.52 M
Day Typical Price
5.13
7.0E-4
0.82
0.0259
0.01
12.15
0.0021
0.04
0.0015
4.85
Accumulation Distribution
0.025
1.1 M
0.0706
0.15
0.0485
N/A
N/A
N/A
N/A
N/A
Market Facilitation Index
0.13
N/A
0.06
0.0042
5.0E-4
N/A
N/A
N/A
N/A
N/A
Daily Balance Of Power
(0.54)
1.0
0.1667
0.7857
(6.00)
9.2 T
(9,223,372,036,855)
0.0
0.0
0.0
Period Momentum Indicator
(0.07)
1.0E-4
0.01
0.0033
(0)
0.38
(0.0005)
N/A
N/A
N/A
Rate Of Daily Change
0.99
1.17
1.01
1.15
0.77
1.03
0.81
1.0
1.0
1.0
Day Median Price
5.14
7.0E-4
0.82
0.0264
0.0101
12.15
0.0021
0.04
0.0015
4.85
Price Action Indicator
(0.04)
1.0E-4
0.005
3.0E-4
(0)
0.19
(0.0003)
N/A
N/A
N/A
Coefficient Of Variation
2002.92
935.23
5527.39
(5,236)
2425.5
41090.69
997.54
N/A
N/A
760.17
Mean Deviation
1.78
8.85
2.71
4.73
11.32
0.6411
8.86
N/A
N/A
2.38
Jensen Alpha
0.1929
1.49
0.1789
(0.06)
1.68
(0.02)
2.44
N/A
N/A
0.6415
Total Risk Alpha
0.5873
3.83
0.6726
0.9502
3.6
0.3146
4.92
N/A
N/A
1.58
Sortino Ratio
0.1153
0.1039
0.0442
N/A
0.0487
N/A
0.074
N/A
N/A
0.1138
Downside Variance
5.43
244.66
20.18
N/A
298.86
N/A
710.91
N/A
N/A
53.42
Standard Deviation
2.73
13.96
3.66
6.43
17.22
1.9
18.36
N/A
N/A
5.32
Kurtosis
8.84
2.69
0.335
0.944
4.48
15.93
6.05
N/A
N/A
15.02
Potential Upside
3.7
33.33
5.68
11.83
30.77
3.23
55.56
N/A
N/A
12.31
Treynor Ratio
0.271
20.0
0.0651
(0.25)
0.1014
0.0562
0.4266
N/A
N/A
(2.06)
Maximum Drawdown
19.23
80.0
17.98
32.2
121.43
15.54
114.67
N/A
N/A
43.08
Variance
7.48
194.76
13.38
41.3
296.42
3.6
337.17
N/A
N/A
28.25
Market Risk Adjusted Performance
0.281
20.01
0.0751
(0.24)
0.1114
0.0662
0.4366
N/A
N/A
(2.05)
Risk Adjusted Performance
0.0491
0.0997
0.023
(0.01)
0.0443
0.0076
0.0942
N/A
N/A
0.1195
Skewness
1.8
1.24
(0.13)
0.2741
0.9316
(2.15)
1.54
N/A
N/A
2.74
Semi Deviation
2.03
8.02
3.45
N/A
12.74
N/A
9.81
N/A
N/A
2.42
Information Ratio
0.0983
0.1164
0.0542
0.0015
0.0489
0.0721
0.1074
N/A
N/A
0.1564
Value At Risk
(4.19)
(16.67)
(7.14)
(10.71)
(23.53)
(2.77)
(15.38)
N/A
N/A
(2.32)
Expected Short fall
(2.23)
(23.96)
(3.26)
N/A
(18.50)
N/A
(43.61)
N/A
N/A
(9.37)
Downside Deviation
2.33
15.64
4.49
N/A
17.29
N/A
26.66
N/A
N/A
7.31
Semi Variance
4.12
64.35
11.93
N/A
162.29
N/A
96.18
N/A
N/A
5.85

Bioharvest Sciences Competition Performance Charts

Five steps to successful analysis of Bioharvest Sciences Competition

Bioharvest Sciences' competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Bioharvest Sciences in relation to its competition. Bioharvest Sciences' competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of Bioharvest Sciences in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Bioharvest Sciences' competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Bioharvest Sciences, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Bioharvest Sciences position

In addition to having Bioharvest Sciences in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Munis Funds Thematic Idea Now

Munis Funds
Munis Funds Theme
Funds or Etfs that invest in fixed income securities issued by states, cities, and towns as well as other public entities. The Munis Funds theme has 41 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Munis Funds Theme or any other thematic opportunities.
View All  Next Launch
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
Note that the Bioharvest Sciences information on this page should be used as a complementary analysis to other Bioharvest Sciences' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.

Other Consideration for investing in Bioharvest OTC Stock

If you are still planning to invest in Bioharvest Sciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Bioharvest Sciences' history and understand the potential risks before investing.
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Equity Valuation
Check real value of public entities based on technical and fundamental data
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY